Please login to the form below

Not currently logged in

Verily and Janssen to collaborate on home-based COVID-19 immune response study

Study will collect information about how COVID-19 affects the immune system

Life sciences research organisation Verily has partnered with Janssen Research & Development on a home-based study to investigate the early immune system response to COVID-19 infection.

The COVID-19 Immune Response Study will collect detailed information about how the SARS-CoV-2 virus affects the immune system, as soon as someone tests positive for COVID-19.

It will enrol participants with a confirmed, positive COVID-19 diagnosis, and the volunteers will participate from home.

Researchers will collect biological measurements, clinical and epidemiological data at the time of COVID-19 testing.

This information will be use to characterise biomarkers associated with progression of disease resulting from COVID-19 infection, over 28 days.

“Acute respiratory distress syndrome caused by SARS-COV-2 and other viral and bacterial pathogens carries with it a high mortality rate, and more than 2.2 million people will suffer each year as a result,” said James Merson, global head of infectious diseases R&D, Janssen.

“Since immune response patterns observed in COVID-19 patients are similar to those caused by other respiratory pathogens, it is our hope to apply the findings from this study beyond COVID-19 to other illnesses that carry a high patient burden,” he added.

The researchers will also collect real-world data from participants from up to two years prior to enrolment in the study and up to two years following the last study assessment.

“There is a critical need for studies to identify biomarkers and potential signals which will give clinicians the ability to make evidence-based treatment decisions, allocate resources and facilitate more meaningful conversations with patients and families about the anticipated disease trajectory,” said Faith Holmes, primary investigator of the COVID-19 Immune Response Study.

“This study will have the ability to contribute to a myriad of future studies to shed some light on these issues,” she added.

Verily is also conducting another programme – the Baseline COVID-19 testing programme – to advance and expand testing and containment for COVID-19 in the US.

Article by
Lucy Parsons

10th February 2021

From: Research



PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....